CAPRICOR THERAPEUTICS, INC.·4

Nov 4, 9:25 AM ET

Krasney Karen 4

4 · CAPRICOR THERAPEUTICS, INC. · Filed Nov 4, 2022

Insider Transaction Report

Form 4
Period: 2022-11-03
Krasney Karen
EVP, GENERAL COUNSEL
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-11-0318,9320 total
    Exercise: $1.39Exp: 2022-11-13Common Stock (18,932 underlying)
  • Exercise/Conversion

    Common Stock

    2022-11-03$1.39/sh+18,932$26,31520,047 total
Footnotes (2)
  • [F1]This option was granted on November 13, 2012 and was previously reported as covering 189,320 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
  • [F2]25% of the shares vested immediately, with the remainder vesting 1/36th on the first day of each month commencing December 1, 2012.

Documents

1 file
  • 4
    form4-11042022_091102.xmlPrimary